Diagnostic Hybrids is now a wholly owned subsidiary of Quidel.

 


14th International Thyroid Congress

Sep 11-16, 2010

Diagnostic Hybrids will be sponsoring the 14th International Thyroid Congress in Paris, France. September 11-16, 2010.

http://www.itc2010.com/   


Diagnostic Hybrids Satellite Symposium

Palais Des Congress Room 342 AB

Monday 13 September, 2010 • 18:30h – 19:30h PM

 

SCIENTIFIC PROGRAM

 

Role and structure of the TSH receptor in Graves’ disease

Rebecca S. BAHN, M.D. (Mayo Clinic, Rochester, MN, USA) 

 

Development and FDA clearance of a novel bioassay for stimulating TSH receptor autoantibodies (Thyretain®)

Paul D. OLIVO, M.D., Ph.D. (DHI, Athens, OH, USA)

 

Thyretain in pediatric Graves’ disease

Rosalind S. BROWN, M.D. (Harvard Children Hospital, Boston, MA, USA)

 

Thyretain is a functional indicator of Graves’ thyroidal and orbital disease

Katharina A. PONTO, M.D. (Gutenberg University, Mainz, Germany)

 

ROUND-TABLE DISCUSSION 

 

Dinner and Refreshments will be provided immediately following symposium